Carl Crysler

1.1k total citations
37 papers, 782 citations indexed

About

Carl Crysler is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Carl Crysler has authored 37 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Oncology and 12 papers in Hematology. Recurrent topics in Carl Crysler's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Cell Adhesion Molecules Research (6 papers). Carl Crysler is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Cell Adhesion Molecules Research (6 papers). Carl Crysler collaborates with scholars based in United States, Belgium and United Kingdom. Carl Crysler's co-authors include Bruce E. Tomczuk, Carl L. Manthey, Mark R. Player, Tianbao Lu, Renée L. DesJarlais, John Spurlino, Joseph J. Villafranca, Wolfgang von der Saal, Christopher J. Molloy and Margery A. Chaikin and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Carl Crysler

36 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Crysler United States 19 325 304 166 145 71 37 782
Michael N. Greco United States 18 489 1.5× 432 1.4× 125 0.8× 157 1.1× 57 0.8× 32 967
Robert A. Galemmo United States 19 262 0.8× 494 1.6× 61 0.4× 158 1.1× 143 2.0× 46 1.0k
Jack A. Kauffman United States 16 365 1.1× 416 1.4× 99 0.6× 81 0.6× 122 1.7× 30 853
William C. Ripka United States 21 403 1.2× 722 2.4× 203 1.2× 204 1.4× 114 1.6× 38 1.1k
Lawrence A. Reiter United States 15 268 0.8× 358 1.2× 62 0.4× 100 0.7× 52 0.7× 32 697
Douglas G. Batt United States 18 405 1.2× 274 0.9× 57 0.3× 92 0.6× 33 0.5× 35 803
Brad O. Buckman United States 19 407 1.3× 391 1.3× 103 0.6× 169 1.2× 123 1.7× 37 986
Carol Torcellini United States 10 231 0.7× 290 1.0× 148 0.9× 103 0.7× 53 0.7× 13 801
Laurie Churchill United States 13 260 0.8× 686 2.3× 156 0.9× 263 1.8× 79 1.1× 20 1.3k
Kathleen M. Gillooly United States 14 145 0.4× 263 0.9× 263 1.6× 166 1.1× 53 0.7× 17 778

Countries citing papers authored by Carl Crysler

Since Specialization
Citations

This map shows the geographic impact of Carl Crysler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Crysler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Crysler more than expected).

Fields of papers citing papers by Carl Crysler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Crysler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Crysler. The network helps show where Carl Crysler may publish in the future.

Co-authorship network of co-authors of Carl Crysler

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Crysler. A scholar is included among the top collaborators of Carl Crysler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Crysler. Carl Crysler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Illig, Carl R., Carl L. Manthey, Sanath K. Meegalla, et al.. (2013). Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6363–6369. 3 indexed citations
2.
Subasinghe, Nalin L., James C. Lanter, Evan E. Opas, et al.. (2012). A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1063–1069. 17 indexed citations
3.
Subasinghe, Nalin L., Ehab M. Khalil, Jeremy Travins, et al.. (2012). Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 22(16). 5303–5307. 7 indexed citations
4.
Zhang, Xuqing, James C. Lanter, Chaozhong Cai, et al.. (2011). Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5577–5582. 18 indexed citations
5.
Zhang, Xuqing, Cuifen Hou, Evan E. Opas, et al.. (2011). Design, synthesis and SAR of indazole and benzoisoxazole containing 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(20). 6042–6048. 8 indexed citations
6.
Kervinen, Jukka, Carl Crysler, Shariff Bayoumy, et al.. (2010). Potency variation of small-molecule chymase inhibitors across species. Biochemical Pharmacology. 80(7). 1033–1041. 21 indexed citations
7.
Wilson, Kenneth J., Carl R. Illig, Mark J. Wall, et al.. (2010). Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(13). 3925–3929. 9 indexed citations
8.
Huang, Hui, William H. Parsons, Carsten J. Schubert, et al.. (2009). Pyrido[2,3-d]pyrimidin-5-ones: A Novel Class of Antiinflammatory Macrophage Colony-Stimulating Factor-1 Receptor Inhibitors. Journal of Medicinal Chemistry. 52(4). 1081–1099. 36 indexed citations
9.
Meegalla, Sanath K., Mark J. Wall, Kenneth J. Wilson, et al.. (2008). Structure-based optimization of a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(12). 3632–3637. 26 indexed citations
10.
Illig, Carl R., Mark J. Wall, Kenneth J. Wilson, et al.. (2008). Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 18(5). 1642–1648. 40 indexed citations
11.
Kreutter, K. D., Tianbao Lu, Lily Lee, et al.. (2008). Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif. Bioorganic & Medicinal Chemistry Letters. 18(9). 2865–2870. 24 indexed citations
12.
Winters, Michael P., Carl Crysler, Nalin L. Subasinghe, et al.. (2008). Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor. Bioorganic & Medicinal Chemistry Letters. 18(6). 1926–1930. 28 indexed citations
13.
Lee, Lily, K. D. Kreutter, Wenxi Pan, et al.. (2007). 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6266–6269. 35 indexed citations
14.
Raboisson, Pierre, Carl L. Manthey, Margery A. Chaikin, et al.. (2006). Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin. European Journal of Medicinal Chemistry. 41(7). 847–861. 10 indexed citations
15.
Moriarty, K.J.M., Holly K. Koblish, Thomas Garrabrant, et al.. (2006). The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(22). 5778–5783. 54 indexed citations
16.
Subasinghe, Nalin L., Jeremy Travins, Hui Huang, et al.. (2006). A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 16(8). 2200–2204. 11 indexed citations
17.
Leonard, Kristi, Wenxi Pan, Renée L. DesJarlais, et al.. (2005). Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids. Bioorganic & Medicinal Chemistry Letters. 15(10). 2679–2684. 20 indexed citations
18.
Tomczuk, Bruce E., Tianbao Lu, Richard Söll, et al.. (2003). Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1495–1498. 24 indexed citations
19.
Newman, Roland, Kandasamy Hariharan, Mitchell E. Reff, et al.. (2001). Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees. Clinical Immunology. 98(2). 164–174. 45 indexed citations
20.
Kopia, Gregory A., et al.. (1988). Evaluation of the Acute Hemodynamic Effects and Pharmacokinetics of Coronary Thrombolysis Produced by Intravenous Tissue-Type Plasminogen Activator in the Anesthetized Dog. Journal of Cardiovascular Pharmacology. 12(3). 308–316. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael N. Greco Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Jack A. Kauffman Breakdown of academic impact, for papers by William C. Ripka Breakdown of academic impact, for papers by Lawrence A. Reiter Breakdown of academic impact, for papers by Douglas G. Batt Breakdown of academic impact, for papers by Brad O. Buckman Breakdown of academic impact, for papers by Carol Torcellini Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by Kathleen M. Gillooly
Rankless by CCL
2026